Towards the first inhibitors of trihydroxynaphthalene reductase from Curvularia lunata: synthesis of artificial substrate, homology modelling and initial screening

Bioorg Med Chem. 2008 Jun 1;16(11):5881-9. doi: 10.1016/j.bmc.2008.04.066. Epub 2008 Apr 29.

Abstract

Trihydroxynaphthalene reductase (3HNR) is an essential enzyme in the biosynthesis of fungal melanin and it represents an emerging target for the development of new fungicides and antimicotics. To promote the discovery of new inhibitors, an improved chemical synthesis of the artificial substrate 2,3-dihydro-2,5-dihydroxy-4H-benzopyran-4-one (DDBO) was developed. A series of compounds were screened on 3HNR from Curvularia lunata, a known plant pathogen and an opportunistic human pathogen, and several structurally diverse hits were obtained. Homology modelling of 3HNR from C. lunata can explain their binding modes and will enable further structure-based design of new and improved inhibitors.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Amino Acid Sequence
  • Ascomycota
  • Benzopyrans / chemical synthesis*
  • Benzopyrans / metabolism
  • Enzyme Inhibitors / chemistry*
  • Enzyme Inhibitors / pharmacology
  • Fungal Proteins / antagonists & inhibitors*
  • Fungal Proteins / chemistry*
  • Fungal Proteins / metabolism
  • Melanins / antagonists & inhibitors
  • Melanins / biosynthesis
  • Models, Molecular*
  • Molecular Sequence Data
  • Oxidoreductases Acting on CH-CH Group Donors / antagonists & inhibitors*
  • Oxidoreductases Acting on CH-CH Group Donors / chemistry*
  • Oxidoreductases Acting on CH-CH Group Donors / metabolism
  • Recombinant Proteins / antagonists & inhibitors
  • Recombinant Proteins / chemistry
  • Recombinant Proteins / metabolism
  • Structural Homology, Protein*
  • Substrate Specificity

Substances

  • 2,3-dihydro-2,5-dihydroxy-4H-benzopyran-4-one
  • Benzopyrans
  • Enzyme Inhibitors
  • Fungal Proteins
  • Melanins
  • Recombinant Proteins
  • tetrahydroxynaphthalene reductase
  • Oxidoreductases Acting on CH-CH Group Donors